全文获取类型
收费全文 | 1813篇 |
免费 | 84篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 52篇 |
妇产科学 | 10篇 |
基础医学 | 252篇 |
口腔科学 | 36篇 |
临床医学 | 123篇 |
内科学 | 416篇 |
皮肤病学 | 43篇 |
神经病学 | 187篇 |
特种医学 | 23篇 |
外科学 | 221篇 |
综合类 | 9篇 |
预防医学 | 47篇 |
眼科学 | 35篇 |
药学 | 171篇 |
中国医学 | 4篇 |
肿瘤学 | 256篇 |
出版年
2023年 | 11篇 |
2022年 | 16篇 |
2021年 | 40篇 |
2020年 | 23篇 |
2019年 | 27篇 |
2018年 | 36篇 |
2017年 | 29篇 |
2016年 | 35篇 |
2015年 | 35篇 |
2014年 | 37篇 |
2013年 | 59篇 |
2012年 | 89篇 |
2011年 | 122篇 |
2010年 | 60篇 |
2009年 | 45篇 |
2008年 | 103篇 |
2007年 | 119篇 |
2006年 | 123篇 |
2005年 | 119篇 |
2004年 | 126篇 |
2003年 | 128篇 |
2002年 | 113篇 |
2001年 | 26篇 |
2000年 | 24篇 |
1999年 | 36篇 |
1998年 | 27篇 |
1997年 | 18篇 |
1996年 | 23篇 |
1995年 | 21篇 |
1994年 | 15篇 |
1993年 | 17篇 |
1992年 | 18篇 |
1991年 | 9篇 |
1990年 | 6篇 |
1989年 | 21篇 |
1988年 | 10篇 |
1987年 | 14篇 |
1986年 | 12篇 |
1985年 | 14篇 |
1984年 | 20篇 |
1983年 | 15篇 |
1982年 | 9篇 |
1981年 | 9篇 |
1980年 | 13篇 |
1979年 | 5篇 |
1978年 | 2篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1973年 | 2篇 |
1960年 | 3篇 |
排序方式: 共有1898条查询结果,搜索用时 31 毫秒
71.
Kikuaki Yoshida Ayaka Sakaki Yoriko Matsuyama Toshiki Mushino Masanori Matsumoto Takashi Sonoki Shinobu Tamura 《Internal medicine (Tokyo, Japan)》2022,61(3):407
A 57-year-old man without underlying diseases presented with fatigue, loss of appetite, and jaundice 1 week after receiving the first dose of the BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccine and showed hemolytic anemia with fragmented erythrocytes and severe thrombocytopenia 2 weeks after receiving the vaccine. An a disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13 (ADAMTS13) activity level of <10% and ADAMTS13 inhibitor positivity confirmed the diagnosis of acquired thrombotic thrombocytopenic purpura (TTP). Combination therapy with plasma exchange, corticosteroid, and rituximab improved the clinical outcome. We herein report the first Japanese case of TTP possibly associated with vaccination. Physicians should be alert for this rare but life-threatening hematological complication following COVID-19 vaccination. 相似文献
72.
Maho Iwamoto Kimitoshi Kato Yoshiaki Kusumi Shinobu Masuda Tomohiro Nakayama Mitsuhiko Moriyama 《Internal medicine (Tokyo, Japan)》2022,61(3):323
Celiac disease is a systemic autoimmune disorder leading to manifestations of malabsorption syndrome. A 47-year-old Japanese man developed severe diarrhea after surgery for gastric cancer. The diarrhea persisted for seven months, leading to a state of malabsorption. Celiac disease was suspected based on small bowel capsule endoscopy findings. The duodenal findings observed during gastric cancer surgery were reassessed, and Marsh-Oberhuber classification type 3c celiac disease was diagnosed. The anti-tissue glutaminase antibody test results were positive. The patient was started on a gluten-free diet, following which the diarrhea resolved, and the nutritional status improved. Adjuvant therapy after gastric cancer surgery was initiated. 相似文献
73.
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma 总被引:7,自引:3,他引:7
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Tagawa H Suguro M Tsuzuki S Matsuo K Karnan S Ohshima K Okamoto M Morishima Y Nakamura S Seto M 《Blood》2005,106(5):1770-1777
Diffuse large B-cell lymphoma (DLBCL) comprises molecularly distinct subgroups such as activated B-cell-like (ABC) and germinal center B-cell-like (GCB) DLBCLs. We previously reported that CD5(+) and CD5(-)CD10(+) DLBCL constitute clinically relevant subgroups. To determine whether these 2 subgroups are related to ABC and GCB DLBCLs, we analyzed the genomic imbalance of 99 cases (36 CD5(+), 19 CD5(-)CD10(+), and 44 CD5(-)CD10(-)) using array-based comparative genomic hybridization (CGH). Forty-six of these cases (22 CD5(+), 7 CD5(-)CD10(+), and 17 CD5(-)CD10(-)) were subsequently subjected to gene-expression profiling, resulting in their division into 28 ABC (19 CD5(+) and 9 CD5(-)CD10(-)) and 18 GCB (3 CD5(+), 7 CD5(-)CD10(+), and 8 CD5(-)CD10(-)) types. A comparison of genome profiles of distinct subgroups of DLBCL demonstrated that (1) ABC DLBCL is characterized by gain of 3q, 18q, and 19q and loss of 6q and 9p21, and GCB DLBCL is characterized by gain of 1q, 2p, 7q, and 12q; (2) the genomic imbalances characteristic of the CD5(+) and CD5(-)CD10(+) groups were similar to those of the ABC and GCB types, respectively. These findings suggest that CD5(+) and CD5(-)CD10(+) subgroups are included, respectively, in the ABC and GCB types. Finally, when searching for genomic imbalances that affect patients' prognosis, we found that 9p21 loss (p16(INK4a) locus) marks the most aggressive type of DLBCL. 相似文献
74.
75.
76.
Dedong Kang PhD Tomoko Nakayama MD PhD Mayuko Togashi PhD Masuki Yamamoto MD PhD Mikiko Takahashi MD Shinobu Kunugi MD PhD Masamichi Ishizaki PhD Yuh Fukuda MD PhD 《Human pathology》2009,40(11):1618-1627
Acute respiratory distress syndrome is a severe disease, the treatment and pathophysiology of which are not completely established. The pathology of acute respiratory distress syndrome involves diffuse alveolar damage, which comprises severe alveolar epithelial cell damage, hyaline membrane formation, and festinate myofibroblast proliferation and fibrosis in the intra-alveolar spaces. We performed a clinicopathologic investigation of 26 autopsy cases of diffuse alveolar damage. Three cases of them were diagnosed as acute interstitial pneumonia that is idiopathic illness and resembles pathologically organizing diffuse alveolar damage. Immunohistochemical staining for types I and IV collagen, α-smooth muscle actin, and Ki-67 was carried out, and the sites of myofibroblast proliferation and type I collagen production were examined. All diffuse alveolar damage cases in the proliferative phase showed intra-alveolar myofibroblast proliferation. When diffuse alveolar damage was diagnosed pathologically as being due to severe infection, all 7 patients showed multiple organ dysfunction syndrome, whereas only 2 of 7 patients showed interstitial myofibroblast proliferation. When diffuse alveolar damage was attributed to tumor treatment with chemotherapy or to drug toxicity, 3 of 16 patients showed multiple organ dysfunction syndrome; 15 of 16 showed interstitial myofibroblast proliferation, 3 of 3 acute interstitial pneumonia patients did not show multiple organ dysfunction syndrome; and 3 of 3 acute interstitial pneumonia showed marked interstitial myofibroblast proliferation. These results suggest that the pathophysiologic mechanism of diffuse alveolar damage caused by severe infection is one of systemic circulation disturbance, although the mechanism underlying diffuse alveolar damage due to tumor with chemotherapy or drug toxicity appears to involve interstitial pneumonia-like lesions that are similar to acute interstitial pneumonia. 相似文献
77.
78.
79.
Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice 总被引:17,自引:0,他引:17
Kanatani A Mashiko S Murai N Sugimoto N Ito J Fukuroda T Fukami T Morin N MacNeil DJ Van der Ploeg LH Saga Y Nishimura S Ihara M 《Endocrinology》2000,141(3):1011-1016
Neuropeptide Y (NPY) increases food intake through the action of hypothalamic NPY receptors. At least six subtypes of NPY, peptide YY (PYY), and pancreatic polypeptide (PP) receptors have been identified in mice. Although the involvement of Y1 and Y5 receptors in feeding regulation has been suggested, the relative importance of each of these NPY receptors and the participation of a novel feeding receptor are still unclear. To address this issue, we generated a Y1 receptor-deficient (Y1-/-) and a Y5 receptor-deficient (Y5-/-) mouse line in which we directly compared the orexigenic effects of NPY and its analogs after intracerebroventricular (icv) administration. The icv NPY-induced food intake was remarkably reduced in Y1-/- mice, but was not significantly altered by inactivation of the Y5 receptor. The Y1 receptor therefore plays a dominant role in NPY-induced feeding. Stimulation of feeding by moderately selective Y5 agonists [PYY-(3-36), human PP, and bovine PP] was reduced in Y5-/- mice, although food intake did not decrease to vehicle control levels. These results indicate that the Y5 receptor functions as one of the feeding receptors. In addition, the finding that Y5-preferring agonists still induce food intake in Y5-/- mice suggests a role for another NPY receptor(s), including the possibility of novel NPY receptors. Surprisingly, despite the limited efficacy of PYY-(3-36) and PPs at the Y1 receptor, food consumption induced by these agonists was significantly diminished in Y1-/- mice compared with that in wild-type controls. These observations suggest that the feeding stimulation induced by NPY and its analogs may be directly or indirectly modulated by the action of the Y1 receptor. We conclude that multiple NPY receptors, possibly including the novel feeding receptor, are involved in the feeding response evoked by NPY and its analogs. Among them, the Y1 receptor plays a key role in NPY-induced feeding in mice. 相似文献
80.
Rintaro Noro Kazufumi Honda Kengo Nagashima Noriko Motoi Shinobu Kunugi Jun Matsubayashi Susumu Takeuchi Hideaki Shiraishi Tetsuya Okano Ayumi Kashiro Xue Meng Yukihiro Yoshida Shunichi Watanabe Jitsuo Usuda Tatsuya Inoue Huang Wilber Norihiko Ikeda Masahiro Seike Akihiko Gemma Kaoru Kubota 《Cancer science》2022,113(3):1002
Although adjuvant tegafur/uracil (UFT) is recommended for patients with completely resected stage I non‐small‐cell lung cancer (NSCLC) in Japan, only one‐third of cases has received adjuvant chemotherapy (ADJ) according to real‐world data. Therefore, robust predictive biomarkers for selecting ADJ or observation (OBS) without ADJ are needed. Patients who underwent complete resection of stage I lung adenocarcinoma with or without adjuvant UFT were enrolled. The status of ACTN4 gene amplification was analyzed by FISH. Statistical analyses to determine whether the status of ACTN4 gene amplification affected recurrence‐free survival (RFS) were carried out. Formalin‐fixed, paraffin‐embedded samples from 1136 lung adenocarcinomas were submitted for analysis of ACTN4 gene amplification. Ninety‐nine (8.9%) of 1114 cases were positive for ACTN4 gene amplification. In the subgroup analysis of patients aged 65 years or older, the ADJ group had better RFS than the OBS group in the ACTN4‐positive cohort (hazard ratio [HR], 0.084, 95% confidence interval [CI], 0.009‐0.806; P = .032). The difference in RFS between the ADJ group and the OBS group was not significant in ACTN4‐negative cases (all ages: HR, 1.214; 95% CI, 0.848‐1.738; P = .289). Analyses of ACTN4 gene amplification contributed to the decision regarding postoperative ADJ for stage I lung adenocarcinomas, preventing recurrence, improving the quality of medical care, preventing the unnecessary side‐effects of ADJ, and saving medical costs. 相似文献